Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis

D. I. Bernstein, Peter Socrates Creticos, W. W. Busse, R. Cohen, D. F. Graft, W. C. Howland, W. R. Lumry, A. J. Pedinoff, P. H. Ratner, J. Lim, A. Stokes, C. McNally

Research output: Contribution to journalArticle

Abstract

Background: Few clinical trials have directly compared lite efficacy of antihistamines with topical nasal corticosteroids. Objective: The study was performed to compare the efficacy and safety of triamcinolone acetonide nasal spray at a dose of 110 μg in each nostril once daily with 10 mg of oral astemizole once daily for the treatment of seasonal allergic rhinitis. Methods: A multicenter, double-blind, parallel-group study was conducted in 239 patients who were randomized to receive either triamcinolone acetonide or astemizole. A 5-day, drug-free, lead-in period was followed by 4 weeks of double-blind treatment. One hundred/four patients treated with triamcinolone acetonide and 105 patients treated with astemizole could be evaluated. Results: Overall, triamcinolone acetonide was more effective than astemizole in reducing total nasal symptoms, nasal stuffiness, nasal itching, and sneezing (p ≤ 0.01). Triamcinolone acetonide was superior to astemizole at weeks 1, 2, and 3 in reduction of the total nasal symptom score (p ≤ 0.0401) and in reduction of nasal stuffiness (p ≤ 0.05). Improvements in individual nasal symptoms (itching, postnasal drip, runny nose, and sneezing) were greater for triamcinolone acetonide at week 2 (p ≤ 0.01). Ocular symptoms improved from baseline in both groups. When pollen counts were correlated to mean nasal rhinitis scores, the triamcinolone acetonide group showed continued improvement front week 1 to week 2 in nasal symptoms when pollen counts were at their highest. During the same period, patients treated with astemizole failed to show improvement from week 1 to week 2. This study demonstrated that once daily administration of triamcinolone acetonide was more effective than astemizole for controlling nasal symptoms of seasonal allergic rhinitis, especially during the peak pollination period.

Original languageEnglish (US)
Pages (from-to)749-755
Number of pages7
JournalThe Journal of Allergy and Clinical Immunology
Volume97
Issue number3
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Astemizole
Ambrosia
Triamcinolone Acetonide
Nebulizers and Vaporizers
Nose
Therapeutics
Sneezing
Seasonal Allergic Rhinitis
Pruritus
Pollen
Allergic Rhinitis
Nasal Sprays
Pollination
Histamine Antagonists
Rhinitis

Keywords

  • allergic rhinitis
  • antihistamine
  • astemizole
  • nasal corticosteroid
  • Triamcinolone acetonide

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. / Bernstein, D. I.; Creticos, Peter Socrates; Busse, W. W.; Cohen, R.; Graft, D. F.; Howland, W. C.; Lumry, W. R.; Pedinoff, A. J.; Ratner, P. H.; Lim, J.; Stokes, A.; McNally, C.

In: The Journal of Allergy and Clinical Immunology, Vol. 97, No. 3, 1996, p. 749-755.

Research output: Contribution to journalArticle

Bernstein, DI, Creticos, PS, Busse, WW, Cohen, R, Graft, DF, Howland, WC, Lumry, WR, Pedinoff, AJ, Ratner, PH, Lim, J, Stokes, A & McNally, C 1996, 'Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis', The Journal of Allergy and Clinical Immunology, vol. 97, no. 3, pp. 749-755. https://doi.org/10.1016/S0091-6749(96)80151-5
Bernstein, D. I. ; Creticos, Peter Socrates ; Busse, W. W. ; Cohen, R. ; Graft, D. F. ; Howland, W. C. ; Lumry, W. R. ; Pedinoff, A. J. ; Ratner, P. H. ; Lim, J. ; Stokes, A. ; McNally, C. / Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. In: The Journal of Allergy and Clinical Immunology. 1996 ; Vol. 97, No. 3. pp. 749-755.
@article{f2e6b66379b74924b40cb01cd4692381,
title = "Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis",
abstract = "Background: Few clinical trials have directly compared lite efficacy of antihistamines with topical nasal corticosteroids. Objective: The study was performed to compare the efficacy and safety of triamcinolone acetonide nasal spray at a dose of 110 μg in each nostril once daily with 10 mg of oral astemizole once daily for the treatment of seasonal allergic rhinitis. Methods: A multicenter, double-blind, parallel-group study was conducted in 239 patients who were randomized to receive either triamcinolone acetonide or astemizole. A 5-day, drug-free, lead-in period was followed by 4 weeks of double-blind treatment. One hundred/four patients treated with triamcinolone acetonide and 105 patients treated with astemizole could be evaluated. Results: Overall, triamcinolone acetonide was more effective than astemizole in reducing total nasal symptoms, nasal stuffiness, nasal itching, and sneezing (p ≤ 0.01). Triamcinolone acetonide was superior to astemizole at weeks 1, 2, and 3 in reduction of the total nasal symptom score (p ≤ 0.0401) and in reduction of nasal stuffiness (p ≤ 0.05). Improvements in individual nasal symptoms (itching, postnasal drip, runny nose, and sneezing) were greater for triamcinolone acetonide at week 2 (p ≤ 0.01). Ocular symptoms improved from baseline in both groups. When pollen counts were correlated to mean nasal rhinitis scores, the triamcinolone acetonide group showed continued improvement front week 1 to week 2 in nasal symptoms when pollen counts were at their highest. During the same period, patients treated with astemizole failed to show improvement from week 1 to week 2. This study demonstrated that once daily administration of triamcinolone acetonide was more effective than astemizole for controlling nasal symptoms of seasonal allergic rhinitis, especially during the peak pollination period.",
keywords = "allergic rhinitis, antihistamine, astemizole, nasal corticosteroid, Triamcinolone acetonide",
author = "Bernstein, {D. I.} and Creticos, {Peter Socrates} and Busse, {W. W.} and R. Cohen and Graft, {D. F.} and Howland, {W. C.} and Lumry, {W. R.} and Pedinoff, {A. J.} and Ratner, {P. H.} and J. Lim and A. Stokes and C. McNally",
year = "1996",
doi = "10.1016/S0091-6749(96)80151-5",
language = "English (US)",
volume = "97",
pages = "749--755",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis

AU - Bernstein, D. I.

AU - Creticos, Peter Socrates

AU - Busse, W. W.

AU - Cohen, R.

AU - Graft, D. F.

AU - Howland, W. C.

AU - Lumry, W. R.

AU - Pedinoff, A. J.

AU - Ratner, P. H.

AU - Lim, J.

AU - Stokes, A.

AU - McNally, C.

PY - 1996

Y1 - 1996

N2 - Background: Few clinical trials have directly compared lite efficacy of antihistamines with topical nasal corticosteroids. Objective: The study was performed to compare the efficacy and safety of triamcinolone acetonide nasal spray at a dose of 110 μg in each nostril once daily with 10 mg of oral astemizole once daily for the treatment of seasonal allergic rhinitis. Methods: A multicenter, double-blind, parallel-group study was conducted in 239 patients who were randomized to receive either triamcinolone acetonide or astemizole. A 5-day, drug-free, lead-in period was followed by 4 weeks of double-blind treatment. One hundred/four patients treated with triamcinolone acetonide and 105 patients treated with astemizole could be evaluated. Results: Overall, triamcinolone acetonide was more effective than astemizole in reducing total nasal symptoms, nasal stuffiness, nasal itching, and sneezing (p ≤ 0.01). Triamcinolone acetonide was superior to astemizole at weeks 1, 2, and 3 in reduction of the total nasal symptom score (p ≤ 0.0401) and in reduction of nasal stuffiness (p ≤ 0.05). Improvements in individual nasal symptoms (itching, postnasal drip, runny nose, and sneezing) were greater for triamcinolone acetonide at week 2 (p ≤ 0.01). Ocular symptoms improved from baseline in both groups. When pollen counts were correlated to mean nasal rhinitis scores, the triamcinolone acetonide group showed continued improvement front week 1 to week 2 in nasal symptoms when pollen counts were at their highest. During the same period, patients treated with astemizole failed to show improvement from week 1 to week 2. This study demonstrated that once daily administration of triamcinolone acetonide was more effective than astemizole for controlling nasal symptoms of seasonal allergic rhinitis, especially during the peak pollination period.

AB - Background: Few clinical trials have directly compared lite efficacy of antihistamines with topical nasal corticosteroids. Objective: The study was performed to compare the efficacy and safety of triamcinolone acetonide nasal spray at a dose of 110 μg in each nostril once daily with 10 mg of oral astemizole once daily for the treatment of seasonal allergic rhinitis. Methods: A multicenter, double-blind, parallel-group study was conducted in 239 patients who were randomized to receive either triamcinolone acetonide or astemizole. A 5-day, drug-free, lead-in period was followed by 4 weeks of double-blind treatment. One hundred/four patients treated with triamcinolone acetonide and 105 patients treated with astemizole could be evaluated. Results: Overall, triamcinolone acetonide was more effective than astemizole in reducing total nasal symptoms, nasal stuffiness, nasal itching, and sneezing (p ≤ 0.01). Triamcinolone acetonide was superior to astemizole at weeks 1, 2, and 3 in reduction of the total nasal symptom score (p ≤ 0.0401) and in reduction of nasal stuffiness (p ≤ 0.05). Improvements in individual nasal symptoms (itching, postnasal drip, runny nose, and sneezing) were greater for triamcinolone acetonide at week 2 (p ≤ 0.01). Ocular symptoms improved from baseline in both groups. When pollen counts were correlated to mean nasal rhinitis scores, the triamcinolone acetonide group showed continued improvement front week 1 to week 2 in nasal symptoms when pollen counts were at their highest. During the same period, patients treated with astemizole failed to show improvement from week 1 to week 2. This study demonstrated that once daily administration of triamcinolone acetonide was more effective than astemizole for controlling nasal symptoms of seasonal allergic rhinitis, especially during the peak pollination period.

KW - allergic rhinitis

KW - antihistamine

KW - astemizole

KW - nasal corticosteroid

KW - Triamcinolone acetonide

UR - http://www.scopus.com/inward/record.url?scp=9044243019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9044243019&partnerID=8YFLogxK

U2 - 10.1016/S0091-6749(96)80151-5

DO - 10.1016/S0091-6749(96)80151-5

M3 - Article

VL - 97

SP - 749

EP - 755

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 3

ER -